Literature DB >> 16226311

Hematopoietic-specific microRNA expression in human cells.

Shakti H Ramkissoon1, Lori A Mainwaring, Yoji Ogasawara, Keyvan Keyvanfar, J Philip McCoy, Elaine M Sloand, Sachiko Kajigaya, Neal S Young.   

Abstract

We examined expression profiles of hematopoietic tissue-specific microRNAs (miRNAs; miR-142, miR-155, miR-181 and miR-223) in 17 commercially available malignant hematopoietic cell lines and compared to those in highly purified normal human B, T, monocytic and granulocytic lineages. Although malignant cell lines examined showed miRNA expression patterns similar to normal human hematopoietic lineages, the levels of miRNA expression among cell lines and normal cell lineages were considerably different, indicating the significance of miRNAs in human hematopoietic diseases. Further our results showed differences in miRNA expression between mouse and human hematopoietic cells, suggesting important regulatory roles of miRNAs in human hematopoiesis and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226311     DOI: 10.1016/j.leukres.2005.09.001

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  96 in total

1.  Dynamic expression of specific miRNAs during erythroid differentiation of human embryonic stem cells.

Authors:  Hong Lian Jin; Jong Soo Kim; Young June Kim; Su Jin Kim; Hal E Broxmeyer; Kye-Seong Kim
Journal:  Mol Cells       Date:  2012-07-04       Impact factor: 5.034

2.  A simple array platform for microRNA analysis and its application in mouse tissues.

Authors:  Xiaoqing Tang; Jozsef Gal; Xun Zhuang; Wangxia Wang; Haining Zhu; Guiliang Tang
Journal:  RNA       Date:  2007-08-03       Impact factor: 4.942

3.  CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.

Authors:  Robert W Georgantas; Richard Hildreth; Sebastien Morisot; Jonathan Alder; Chang-gong Liu; Shelly Heimfeld; George A Calin; Carlo M Croce; Curt I Civin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-09       Impact factor: 11.205

4.  One SNP in the 3'-UTR of HMGB1 gene affects the binding of target bta-miR-223 and is involved in mastitis in dairy cattle.

Authors:  Liming Li; Jinming Huang; Xiaojian Zhang; Zhihua Ju; Chao Qi; Yan Zhang; Qiuling Li; Changfa Wang; Weiran Miao; Jifeng Zhong; Minghai Hou; Suqin Hang
Journal:  Immunogenetics       Date:  2012-08-09       Impact factor: 2.846

Review 5.  MicroRNAs in platelet production and activation.

Authors:  Leonard C Edelstein; Paul F Bray
Journal:  Blood       Date:  2011-03-01       Impact factor: 22.113

6.  Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils.

Authors:  Maud Deny; Marta Romano; Olivier Denis; Georges Casimir; Mustapha Chamekh
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

7.  The microRNA-30 family is required for vertebrate hepatobiliary development.

Authors:  Nicholas J Hand; Zankhana R Master; Steven F Eauclaire; Daniel E Weinblatt; Randolph P Matthews; Joshua R Friedman
Journal:  Gastroenterology       Date:  2008-12-09       Impact factor: 22.682

8.  A high throughput experimental approach to identify miRNA targets in human cells.

Authors:  Lu Ping Tan; Erwin Seinen; Gerben Duns; Debora de Jong; Ody C M Sibon; Sibrand Poppema; Bart-Jan Kroesen; Klaas Kok; Anke van den Berg
Journal:  Nucleic Acids Res       Date:  2009-09-04       Impact factor: 16.971

9.  Alternative processing of primary microRNA transcripts by Drosha generates 5' end variation of mature microRNA.

Authors:  Haoquan Wu; Chunting Ye; Danielle Ramirez; N Manjunath
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

10.  MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations.

Authors:  Edurne San José-Enériz; José Román-Gómez; Antonio Jiménez-Velasco; Leire Garate; Vanesa Martin; Lucia Cordeu; Amaia Vilas-Zornoza; Paula Rodríguez-Otero; María José Calasanz; Felipe Prósper; Xabier Agirre
Journal:  Mol Cancer       Date:  2009-09-01       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.